• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种植体周围炎样药物相关性颌骨坏死:临床思考与共聚焦激光扫描显微镜下的组织学评估。

Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope.

机构信息

Department of Interdisciplinary Medicine, Complex Operating Unit of Odontostomatology, Aldo Moro University of Bari, Bari, Italy.

Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.

出版信息

Oral Dis. 2022 Sep;28(6):1603-1609. doi: 10.1111/odi.13873. Epub 2021 May 4.

DOI:10.1111/odi.13873
PMID:33844402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9541517/
Abstract

OBJECTIVE

In the recent years, an increasing number of peri-implant medication-related osteonecrosis of the jaw (PI-MRONJ) have been reported in literature, both in oncologic and osteoporotic patients. The aim of this study is to describe 19 cases of patients previously diagnosed as affected by peri-implantitis, who were treated for PI-MRONJ, with consideration on clinical and histopathological features.

MATERIALS AND METHODS

Patients included were affected by postmenopausal osteoporosis and were administered with different antiresorptive drugs. Due to the presence of clinical and radiological signs of peri-implantitis not healed after non-surgical periodontal treatment, they were referred to the Complex Operating Unit of Odontostomatology of the University of Bari. Then, after a drug holiday of at least 3 months and cycles of antibiotics, and after other cycles of periodontal treatment, patients underwent the surgical removal of implant fixtures and surrounding bone.

RESULTS

Although the previous diagnosis of peri-implantitis, the histopathological analysis with both conventional and confocal laser scanner microscopy confirmed the diagnosis of peri-implantitis-like MRONJ.

CONCLUSION

Peri-implantitis not healed after conventional treatment in patients at risk on MRONJ occurrence should be considered as peri-implantitis-like PI-MRONJ and treated as required in order to get complete healing of the pathological condition, thus avoiding delay in the diagnosis.

摘要

目的

近年来,文献中报道了越来越多的与种植体相关的颌骨骨髓炎(PI-MRONJ)病例,这些病例既有发生在肿瘤患者,也有发生在骨质疏松患者。本研究旨在描述 19 例先前被诊断为患有种植体周围炎的患者,这些患者因 PI-MRONJ 而接受治疗,并考虑了其临床和组织病理学特征。

材料和方法

纳入的患者患有绝经后骨质疏松症,并接受了不同的抗吸收药物治疗。由于存在种植体周围炎的临床和影像学迹象,且这些迹象在非手术牙周治疗后未愈合,因此他们被转诊到巴里大学口腔颌面外科综合操作单位。然后,在至少 3 个月的停药期和抗生素周期后,以及在其他牙周治疗周期后,患者接受了种植体固定装置和周围骨的手术切除。

结果

尽管先前诊断为种植体周围炎,但常规和共聚焦激光扫描显微镜的组织病理学分析证实了种植体周围炎样 MRONJ 的诊断。

结论

在有发生 MRONJ 风险的患者中,经常规治疗后未愈合的种植体周围炎应被视为种植体周围炎样 PI-MRONJ,并根据需要进行治疗,以实现病理性病变的完全愈合,从而避免延误诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/707bc52c5507/ODI-28-1603-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/f9cec12048ff/ODI-28-1603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/3d0200ee33d2/ODI-28-1603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/522937181b6a/ODI-28-1603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/a8f6146889c5/ODI-28-1603-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/707bc52c5507/ODI-28-1603-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/f9cec12048ff/ODI-28-1603-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/3d0200ee33d2/ODI-28-1603-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/522937181b6a/ODI-28-1603-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/a8f6146889c5/ODI-28-1603-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24e7/9541517/707bc52c5507/ODI-28-1603-g004.jpg

相似文献

1
Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope.种植体周围炎样药物相关性颌骨坏死:临床思考与共聚焦激光扫描显微镜下的组织学评估。
Oral Dis. 2022 Sep;28(6):1603-1609. doi: 10.1111/odi.13873. Epub 2021 May 4.
2
Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?种植体周围药物相关性颌骨坏死的临床特征:与种植体周围炎有关联吗?
J Craniomaxillofac Surg. 2016 Dec;44(12):1945-1951. doi: 10.1016/j.jcms.2016.09.018. Epub 2016 Oct 6.
3
Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.接受抗吸收药物治疗患者的牙种植体临床及影像学结果:连续病例系列研究
J Oral Implantol. 2023 Feb 1;49(1):39-45. doi: 10.1563/aaid-joi-D-21-00035.
4
Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.药物相关性颌骨坏死:双膦酸盐治疗患者与抗吸收-抗血管生成药物治疗患者的风险因素
Minerva Stomatol. 2017 Aug;66(4):135-140. doi: 10.23736/S0026-4970.17.04056-0. Epub 2017 May 10.
5
Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review.药物相关性颌骨坏死继发于种植体周围炎:病例报告及文献复习。
J Oral Implantol. 2021 Dec 1;47(6):502-510. doi: 10.1563/aaid-joi-D-19-00385.
6
Medication-related osteonecrosis of the jaw triggered by endodontic failure in oncologic patients.肿瘤患者因牙髓治疗失败引起的药物相关性颌骨坏死。
Oral Dis. 2023 Oct;29(7):2799-2805. doi: 10.1111/odi.14449. Epub 2022 Dec 15.
7
Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.每年一次静脉输注唑来膦酸治疗骨质疏松症后发生的药物相关性颌骨坏死:8例报告
Quintessence Int. 2016;47(5):433-40. doi: 10.3290/j.qi.a35263.
8
Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw.肿瘤和骨质疏松症药物相关颌骨坏死患者的放射学表现和临床特征。
Sci Rep. 2024 Apr 16;14(1):8744. doi: 10.1038/s41598-024-59500-x.
9
Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).牙种植体作为颌骨药物相关性骨坏死(MRONJ)患者的危险因素。
Br J Oral Maxillofac Surg. 2020 Sep;58(7):771-776. doi: 10.1016/j.bjoms.2020.03.022. Epub 2020 Jul 3.
10
Advanced Peri-Implantitis and Implant Removal as Risk Factors for Osteonecrosis of the Jaw in Patients on Oral Bisphosphonate Therapy.晚期种植体周围炎及种植体取出作为口服双膦酸盐治疗患者颌骨坏死的危险因素。
J Oral Implantol. 2021 Oct 1;47(5):420-426. doi: 10.1563/aaid-joi-D-20-00298.

引用本文的文献

1
Medication-Related osteonecrosis of the jaw involving dental implants: A 16-Year observational study in a single cancer center.与药物相关的颌骨坏死累及牙种植体:在单一癌症中心进行的16年观察性研究。
Clin Oral Investig. 2025 Sep 2;29(9):436. doi: 10.1007/s00784-025-06519-7.
2
Peri-Implant Oral Squamous Cell Carcinoma (OSCC): Clinicopathological Features and Staging Issues.种植体周围口腔鳞状细胞癌(OSCC):临床病理特征与分期问题
Cancers (Basel). 2025 Jun 26;17(13):2149. doi: 10.3390/cancers17132149.
3
Effect of anti-resorptive therapy on implant failure: a systematic review and meta-analysis.

本文引用的文献

1
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.药物相关性颌骨坏死 (MRONJ) 的预防和诊断:意大利 2020 年共识更新。
Int J Environ Res Public Health. 2020 Aug 18;17(16):5998. doi: 10.3390/ijerph17165998.
2
Medication-related osteonecrosis of the jaw in a cancer patient receiving lenvatinib.癌症患者接受仑伐替尼治疗导致的药物相关性颌骨坏死。
Int J Oral Maxillofac Surg. 2019 Dec;48(12):1530-1532. doi: 10.1016/j.ijom.2019.07.010. Epub 2019 Aug 2.
3
Peri-implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
抗吸收治疗对种植体失败的影响:一项系统评价和荟萃分析。
J Periodontal Implant Sci. 2025 Apr;55(2):87-103. doi: 10.5051/jpis.2304040202. Epub 2024 Jul 10.
4
Peri-implant inflammation increases the risk of osteonecrosis in mice treated with bisphosphonate.种植体周围炎症增加了用双膦酸盐治疗的小鼠发生骨坏死的风险。
J Periodontol. 2025 Apr 15. doi: 10.1002/JPER.24-0760.
5
A study of peri-implant tissue clinical parameters in patients starting anti-osteoporosis medication after existing implant function: a prospective cohort study.一项研究表明,在存在种植体功能的情况下,开始使用抗骨质疏松药物后,种植体周围组织临床参数的变化:一项前瞻性队列研究。
Int J Implant Dent. 2024 Nov 5;10(1):50. doi: 10.1186/s40729-024-00569-4.
6
Unraveling the mystery of implant-related sequestration: a biomechanical breakthrough with far-reaching implications.揭开植入物相关骨坏死的谜团:一项具有深远意义的生物力学突破。
J Korean Assoc Oral Maxillofac Surg. 2024 Oct 31;50(5):241-242. doi: 10.5125/jkaoms.2024.50.5.241.
7
Effect of Antiresorptive Drugs on Osseointegrated Dental Implants: A Systematic Review.抗吸收药物对骨结合牙种植体的影响:一项系统评价。
J Clin Med. 2024 Apr 3;13(7):2091. doi: 10.3390/jcm13072091.
8
Biomechanical analysis of alveolar bones with compromised quality supporting a 4-unit implant bridge; a possible association with implant-related sequestration (IRS).分析支持四单位种植桥的质量受损牙槽骨的生物力学特性;与种植体相关的隔离症(IRS)的可能关联。
Clin Oral Investig. 2024 Mar 7;28(3):197. doi: 10.1007/s00784-024-05589-3.
9
A Mapping Review of the Pathogenesis of Peri-Implantitis: The Biofilm-Mediated Inflammation and Bone Dysregulation (BIND) Hypothesis.种植体周围炎发病机制的映射综述:生物膜介导的炎症和骨调节紊乱(BIND)假说。
Cells. 2024 Feb 8;13(4):315. doi: 10.3390/cells13040315.
10
Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate.种植体周炎增加了接受唑来膦酸盐治疗的大鼠中与骨整合种植体相关的药物相关性颌骨坏死的风险。
Sci Rep. 2024 Jan 5;14(1):627. doi: 10.1038/s41598-023-49647-4.
种植体周围疾病和状况:2017 年牙周病和种植体周围病分类世界研讨会第 4 工作组的共识报告。
J Clin Periodontol. 2018 Jun;45 Suppl 20:S286-S291. doi: 10.1111/jcpe.12957.
4
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab.1例接受英夫利昔单抗治疗的克罗恩病患者发生颌骨骨坏死的病例
Am J Case Rep. 2017 Dec 19;18:1351-1356. doi: 10.12659/AJCR.905355.
5
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect.颌骨坏死与血管生成抑制剂:一种罕见但严重副作用的再次出现
Curr Med Chem. 2017;24(28):3068-3076. doi: 10.2174/0929867324666170511113811.
6
Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience.药物相关性颌骨坏死:关于一种新型抗吸收疗法(地诺单抗)的思考及13年经验后的治疗结果
Int J Dent. 2016;2016:1801676. doi: 10.1155/2016/1801676. Epub 2016 Oct 24.
7
Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?种植体周围药物相关性颌骨坏死的临床特征:与种植体周围炎有关联吗?
J Craniomaxillofac Surg. 2016 Dec;44(12):1945-1951. doi: 10.1016/j.jcms.2016.09.018. Epub 2016 Oct 6.
8
Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?阿达木单抗:另一种与颌骨骨坏死相关的药物?
Case Rep Dent. 2016;2016:2856926. doi: 10.1155/2016/2856926. Epub 2016 Mar 21.
9
Osteopontin, osteocalcin and OB-cadherin expression in Synthetic nanohydroxyapatite vs bovine hydroxyapatite cultured Osteoblastic-like cells.合成纳米羟基磷灰石与牛羟基磷灰石培养的成骨样细胞中骨桥蛋白、骨钙素和OB-钙黏蛋白的表达
J Biol Regul Homeost Agents. 2014 Jul-Sep;28(3):523-9.
10
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.美国口腔颌面外科医师协会关于药物相关性颌骨坏死的立场文件——2014年更新版
J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. doi: 10.1016/j.joms.2014.04.031. Epub 2014 May 5.